Semaglutide Raw Powder

Semaglutide Raw Powder – Pharmaceutical-Grade GLP-1 API for Advanced Metabolic Applications

Xi'an Le-Nutra Ingredients Inc is a professional manufacturer and supplier of pharmaceutical quality Semaglutide Raw Powder with a 60,000㎡ GMP-compliant factory, 3,000 tonnes annual production capacity and 99% purity (HPLC) . Our lyophilised API (CAS: 910463-68-2) is a cutting-edge albumin-binding modification with a plasma half-life of 165 hours for once-weekly dosing procedures. With more than 14 years of experience in peptide synthesis and stringent quality control, we offer dependable, traceable raw material to pharmaceutical manufacturers, compounding pharmacies and metabolic research organisations worldwide. All lots come with full documentation (COA, HPLC chromatogram, MSDS) and 98% on-time delivery through refined cold-chain logistics.

Product Specifications

Mechanism of Action and Pharmacological Advantages

Semaglutide Raw Powder is a strong GLP-1 receptor agonist, whose structure has been modified to overcome the instability of the natural peptide. The C-18 fatty diacid side chain linked to Lysine-26 provides high-affinity binding to albumin, which protects against enzymatic destruction by DPP-4.

This elegant molecular design leads to glucose-dependent insulin secretion and at the same time suppression of incorrect glucagon release. It delays stomach emptying and acts on the hypothalamus appetite regions to decrease food intake and cravings.

There is clinical data to suggest that they protect pancreatic β-cells and so have a role in the management of Type 2 diabetes, chronic weight management and reduction of cardiovascular risk. Your formulation teams can use this world-leading peptide for several therapeutic areas.

Industrial Applications Across Pharmaceutical Sectors

Pharmaceutical Formulations: Our raw powder is the basis for sterile subcutaneous injectable products and next-generation oral tablet technologies that require permeation enhancers for improved bioavailability.

Therapeutic Indications: Clinical Formulations: Management of Type 2 diabetes mellitus, evidence-based weight management program, risk reduction of cardiovascular events in high risk patients and protocols for management of chronic renal disease.

Research and Development: Metabolic disease researchers use our API for obesity mechanism research, appetite regulation neurobiology study, cardiovascular protection pathway research and renal protective impact study. Your R&D teams get reproducible experimental results with consistent, high-purity material.

Quality Assurance and Compliance Documentation

Each batch is subjected to thorough multi-stage testing at our ultramodern analytical laboratories. We provide a comprehensive Certificate of Analysis for key quality criteria including peptide content, sequence verification, and impurity profiles.

Your quality teams will receive HPLC chromatograms, Mass Spectrometry data and Certificates of Compliance. We support third party testing requirements with full batch traceability from raw material purchase to final release.

Our production is GMP, ISO and FDA quality system . You can get food, medicine and research grade material that fulfils the global regulation standards and is monitored by the professional QC staff during the procedure.

Storage Stability and Handling Recommendations

Long term storage is at -20°C preferably below -18°C in dry, light protected containers. The lyophilised powder is stable for 2-3 years under these circumstances.

Short term applications can be maintained at 4°C for a period of up to 2 years. Do not store at room temperature for >3 weeks to prevent deterioration.

For transport the cold chain logistics use ice packs or dry ice to reduce thermal stress. The freeze-dried product proved more stable than the liquid product during international shipment.

After reconstitution, allow vials to reach room temperature before adding buffer. Use gentle swirling, not rapid shaking, to reduce mechanical shear stress that can denature the peptide structure and produce aggregation difficulties.

Flexible Packaging and Supply Solutions

We offer packaging solutions that can be adjusted to suit your recipe and production size. Standard pack sizes range from 1g to 1kg (1g, 5g, 10g, 25g, 50g, 100g and 1kg) with bespoke packaging available for niche applications.

Containers are sealed under inert atmosphere and with desiccant protection. We have a 30-day safety stock and supply chain relationships to ensure availability to support your manufacturing schedules.

We are able to handle variable MOQ and bulk orders for pilot scale development projects and big scale commercial manufacture with a capacity of 3,000 tonnes per year. Your buying departments obtain manufacturer direct pricing and consistent supply reliability.

FAQ

Q: How stable is Semaglutide Peptide Raw Powder during transit?

A: The peptide is stable in the lyophilised powder form for short periods at ambient temperatures (up to 2 weeks), however industry norms require shipping with ice packs or dry ice to prevent thermal degradation and maintain integrity on arrival.

Q: Is the raw powder Acetate or TFA as the counter-ion?

A: Pharmaceutical grade Semaglutide is usually Acetate or has been ion exchanged to eliminate Trifluoroacetic acid (TFA) since excessive TFA content is harmful and not acceptable for in vivo use.

Q: What do you do about aggregation problems on reconstitution?

A: GLP-1 peptides have a prevalent problem with aggregation. We recommend that the vial be allowed to equilibrate to room temperature prior to adding buffer and that it be swirled (not shaken) to mix, because the peptide structure can be denatured by mechanical shear stress.

Q: What is the difference between "Peptide Content" and "Purity"?

A: Purity (e.g. 99%) is determined by HPLC as the ratio of target peptide sequence to contaminants. Peptide Content is the net weight of the peptide minus water and counter-ions (salts). A good quality raw powder will have a net peptide content of around 80-90% of the overall powder weight.

Q: Can this powder be directly utilized for oral tablets?

A: The active ingredient is Semaglutide Peptide Raw Powder. But it needs to be prepared in a complicated way with permeability enhancers to make it bioavailable orally. Just the raw powder will not be absorbed at all because of processing by gastric enzymes when taken orally.

Contact Us for Technical Support

Ready to secure pharmaceutical-grade API for your formulation projects with Semaglutide Raw Powder? Contact us at enquiry@lenutra.com for samples, COA review, or partnership discussions.